top of page

Bioprinting 3D tissues for testing COVID-19 therapeutics: an interview with CLECELL


We are grateful for the appreciation and interest regarding our advancements in the pandemic. Here, we present another report regarding our successful development of 3D bioprinted in vitro tissue models, and also the prospects of our highly sophisticated private label printer, U-FAB. We hope our future customers could gain a better understanding of the perks of our particular 3D bioprinting technology. We present our thanks to Ph.D. Bae, our fellow researcher, for her participation in the interview, and also to our staff and manufacturers without whom we couldn’t have made it this far.

For more information regarding the report and our private label product:…/

bottom of page